Case Studies

Page 1 of 30.

Valid calibration of infusion pumps

Infusion pumps deliver medications at programmed rates or intervals. However, incorrect doses can occur if fluids are delivered at inaccurate flow rates, particularly drugs with narrow therapeutic margins, short half-life, high concentration, or the very low flow rates typical for newborn children. Therefore, accurate and prec...

read more

Robust sulfur dioxide emissions monitoring

Air pollution remains the main environmental factor in human ill-health, with about 400,000 premature deaths attributed to ambient air pollution annually in the EU. Industrial processes account for a sizeable share of polluting emissions, including sulfur dioxide (SO2 ), produced by burning fuels containing sulfur compounds an...

read more

Fit for purpose emissions testing

Air pollution remains the main environmental factor in human ill-health, with about 400,000 premature deaths attributed to ambient air pollution annually in the EU. Industrial processes account for a sizeable share of polluting emissions, including sulfur dioxide (SO2 ), produced by burning fuels containing sulfur compounds an...

read more

Standard to certify zero gas purity

The 2008 Air Quality Directive and related legislation measurably improved Europe’s air quality. For example, a 2018 analysis noted a 54 % reduction in early deaths due to nitrogen dioxide (NO2) pollution. Nonetheless, almost all Europeans remained exposed to polluted air, at the cost of 400,000 premature deaths a year in the E...

read more

Trusted MR-guided radiotherapy planning

Europe’s health services face demands for breakthrough cancer therapies assured as safe, personalised, and able to cost-effectively treat patients. In 2020, 2.7 million people in the European Union received a cancer diagnosis. About half underwent radiotherapy, including during diagnosis. Image-guided radiation therapies becam...

read more

Absolute dosimetry for MR-Linacs

Should cancer incidence rates rise as predicted, Europe’s health services will face escalating demands for investment in advanced therapies assured as safe, personalised, and cost-effective. In 2020, 2.7 million people in the European Union received a cancer diagnosis. About half underwent radiotherapy, including during diagno...

read more
Page 1 of 30.
Element 1 Element 2 Element 3 Element 1 Element 1 Element 1 Element 1 Element 1 Logo-Footer